Trellis Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-525
Closed -$266K 67
2023
Q3
$266K Buy
525
+27
+5% +$14.4K 0.12% 72
2023
Q2
$260K Sell
498
-24
-5% -$13K 0.12% 77
2023
Q1
$301K Buy
522
+13
+3% +$7.33K 0.14% 66
2022
Q4
$280K Sell
509
-23
-4% -$12.2K 0.15% 70
2022
Q3
$270K Buy
532
+10
+2% +$5.6K 0.15% 58
2022
Q2
$283K Buy
522
+16
+3% +$8.81K 0.16% 60
2022
Q1
$299K Buy
506
+3
+0.6% +$1.72K 0.15% 62
2021
Q4
$336K Hold
503
0.16% 58
2021
Q3
$288K Hold
503
0.15% 64
2021
Q2
$253K Sell
503
-25
-5% -$11.8K 0.13% 69
2021
Q1
$241K Buy
528
+2
+0.4% +$955 0.14% 69
2020
Q4
$245K Sell
526
-203
-28% -$95.2K 0.15% 67
2020
Q3
$322K Buy
729
+10
+1% +$4.13K 0.23% 43
2020
Q2
$260K Hold
719
0.2% 50
2020
Q1
$203K Buy
+719
New +$227K 0.2% 53
2019
Q4
Sell
-920
Closed -$268K 54
2019
Q3
$268K Hold
920
0.23% 42
2019
Q2
$270K Buy
920
+4
+0.4% +$1.1K 0.23% 41
2019
Q1
$251K Buy
916
+6
+0.7% +$1.49K 0.23% 38
2018
Q4
$204K Sell
910
-415
-31% -$97.4K 0.21% 41
2018
Q3
$323K Hold
1,325
0.29% 30
2018
Q2
$274K Buy
+1,325
New +$281K 0.26% 33

Other funds holding TMO

Trellis Advisors's TMO Position: Q4 2023 in Review

Trellis Advisors sold out of Thermo Fisher Scientific (TMO) in Q4 2023, closing a stake of 525 shares — an estimated $266K sold.

Trellis Advisors first reported a position in TMO in Q2 2018 and held it in 21 quarters. The position peaked at $336K in Q4 2021. 2,488 funds tracked by Wall St. Rank hold TMO as of Q4 2023.

  • Trellis Advisors reported no remaining Thermo Fisher Scientific position as of Q4 2023 after selling out during the quarter.
  • Trellis Advisors sold 525 Thermo Fisher Scientific shares in Q4 2023, an estimated $266K.
  • Trellis Advisors first reported a position in Thermo Fisher Scientific in Q2 2018 and held it in 21 quarters.
  • Trellis Advisors's Thermo Fisher Scientific position peaked at $336K in Q4 2021.
  • 2,488 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2023.

Based on Trellis Advisors's 13F filing for Q4 2023.